FZFuhai Zhou

Fuhai Zhou

*This is an algorithmically generated author record based on publicly available information.

Fuhai Zhou has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prognostic Value of the Charlson Comorbidity Index for Mortality and Machine Learning–Based Prediction in Critically Ill Patients with Paralytic Ileus: Retrospective Cohort Study

    by Hui Feng, Fuhai Zhou, Yi Shen, Zhen Wang, Yiyang Yuan, Wenshan Jing, Zhou Zheng, Hui Peng, Qingsheng Yu

    Background: The burden of paralytic ileus (PI) in the intensive care unit remains high, and the Charlson Comorbidity Index (CCI) is strongly associated with the prognosis of several acute and chronic diseases. However, evidence specifically evaluating the prognostic value of CCI in intensive care unit patients with PI remains limited. Objective: This study aimed to investigate the association between CCI and clinical prognosis in critically ill patients with PI. Methods: In this study, data were extracted from the Medical Information Mart for Intensive Care IV (version 2.2), a large, publicly available critical care database, and used to determine the optimal cut-off value of CCI for predicting mortality in patients with PI using the receiver operating characteristic curves, and the association between CCI and mortality was evaluated using Cox regression and restricted cubic spline analysis. A machine learning (ML) prediction model was then constructed to predict hospital mortality by combining CCI and other clinical characteristics. Results: The study included 863 patients with PI (age: median 65.4, IQR 54.6‐75.5 y; male: 575/863, 66.6%). The receiver operating characteristic curve identified an optimal cut-off value of 4.5 for CCI. The multivariate Cox regression analysis showed that compared to the lowest CCI quartile, patients with elevated CCI levels were more likely to have elevated hospital (Q4: hazard ratio [HR] 2.447, 95% CI 1.210‐4.951), 28-day (Q4: HR 3.891, 95% CI 1.956‐7.740), and 90-day (Q4: HR 3.994, 95% CI 2.224‐7.173) all-cause mortality were significantly associated with elevated CCI levels; however, the association with ICU mortality (Q4: HR 1.892, 95% CI 0.653‐5.480) was weak. Among the 11 ML models, the light gradient boosting machine model performed best, with internal validation results showing an area under the curve of 0.811, a geometric mean of 0.670, and an F 1 -score of 0.895. Conclusions: The CCI is an important predictor of hospital, 28-day, and 90-day all-cause mortality in critically ill patients with PI, and the optimal threshold is 4.5. ML models, including the CCI, show high accuracy in predicting hospital mortality, and the CCI occupies an important position in the model. This suggests that the CCI helps to identify high-risk patients, supports clinical decision-making, and improves prognosis.


  • Open Access

    Calycosin Improves Intestinal Mucosal Barrier Function after Gastrectomy in Rats through Alleviating Bacterial Translocation, Inflammation, and Oxidative Stress

    by Hui Peng, Lei Jin, Qi Zhang, Yi Shen, Zhen Wang, Fuhai Zhou, Qingsheng Yu

    Objective. Calycosin is the main bioactive extract of Astragali Radix with anti-inflammation, antioxidant, and anticancer properties. Here, our study evaluated the protective effects and mechanisms of calycosin on intestinal mucosal barrier under gastrectomy. Methods. After receiving gastrectomy, the rats were administrated with 20mg/kg, 40mg/kg, or 80mg/kg calycosin. Endotoxin, bacterial translocation, and intestinal bacterial flora were assayed. Intestinal injury was detected via hematoxylin and eosin staining. Tight junction indicators (occludin, claudin, and ZO-1) and apoptotic proteins (Bax, Bcl-2, and cleaved caspase 3) were examined in intestinal tissues. Inflammatory indicators (IL-1β, IL-6, and TNF-α) were examined in serum or intestinal specimens via ELISA. Apoptosis was assessed via TUNEL staining. IgA+B cells in intestinal tissues and sIgA in intestinal lumen were examined through immunohistochemistry and ELISA, respectively. Oxidative stress indicators (TSH, SOD, CAT, GSH-Px, and MDA) were also detected via ELISA. Results. Our results showed that calycosin administration decreased endotoxin levels in peripheral blood, intestine, and portal vein blood; lowered the bacterial translocation ratio; and regained the balance among intestinal bacterial flora (comprising bifidobacterium, lactic acid bacillus, enterobacter, enterococcus, aerobic bacteria, and anaerobic bacteria) in the rats with gastrectomy. After calycosin treatment, intestinal mucosal damage of the rats with gastrectomy was ameliorated, with the increase in expression of tight junction proteins. Additionally, calycosin reduced intestinal inflammation, apoptosis, secretion of sIgA, and oxidative stress in the rats with gastrectomy. Conclusion. Altogether, our findings demonstrate that calycosin may improve intestinal mucosal barrier function under gastrectomy via reducing bacterial translocation, inflammation, and oxidative stress.